After completing the maintenance therapy of remission in ALL, the only significant difference pertained to the higher percentage of NKs with intracellular expression of granzyme K. Probably, higher expression of this molecule reflects the activation of compensatory mechanisms of the body, which are aimed at improving the functional capacity of NK cells. The gene discussed is GZMK; the disease is acute lymphoblastic leukemia.